1 |
Breslow, N. E. and Clayton, D. G. (1993). Approximate inference in generalized linear mixed models, Journal of the American Statistical Association, 88, 125-134.
|
2 |
Chung, I., Yoon, S., Yi, S., Kim, B.-H., Yim, S.-V., Jang, I.-J. and Lee, H. (2014). A bioequivalence study of two levofloxacin tablets in healthy male subjects,Traditional and Clinical Pharmacology, 22, 102-105.
DOI
|
3 |
MFDS (2014).Guideline for the Drug Equivalence Test (Notification No. 2014-188, 2014.11.24) (Korean).
|
4 |
Kang, S. (2008). Why is 90% confidence interval used when confidence interval approach is used for testing equivalence?, The Korean Journal of Applied Statistics, 21, 867-873.
DOI
ScienceOn
|
5 |
Lee, Y. and Nelder, J. A. (1996). Hierarchical generalized linear models (with discussion), Journal of the Royal Statistical Society B, 58, 619-656.
|
6 |
Laird, N. M. and Ware, J. H. (1982). Random-effects models for longitudinal data, Biometrics, 38, 963-974.
DOI
ScienceOn
|
7 |
Schuirmann, D. J. (1987). A comparison of the two one-sided test procedure and the power approach for assessing the equivalence of average bioavailability, Journal of Pharmacokinetics and Biopharmaceutics, 15, 657-680.
DOI
|